Suppr超能文献

中国无脉络膜症患者中CHM基因的新型截短突变

Novel truncating mutations of the CHM gene in Chinese patients with choroideremia.

作者信息

Yip Shea Ping, Cheung Tsz Shan, Chu Man Yu, Cheung Suk Chun, Leung Kam Wah, Tsang Kin Ping, Lam Stephen T S, To Chi Ho

机构信息

Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China.

出版信息

Mol Vis. 2007 Nov 27;13:2183-93.

Abstract

PURPOSE

Choroideremia (CHM) is an X-linked retinal degenerative disorder caused by mutations in the CHM gene. The mutations result in malfunction of the Rab escort protein 1 (REP-1). In this study, mutational analysis of the CHM gene was performed on five Chinese families clinically diagnosed with CHM.

METHODS

Denaturing high performance liquid chromatography was used for mutation screening for all 15 exons and flanking intron regions of the CHM gene. Mutations were confirmed and characterized with DNA sequencing. Second samples were later collected for extraction of mRNA and proteins from leukocytes. A non-radioactive protein truncation test (PTT) was developed and used to characterize the truncating nature of the mutations. Immunoblot analysis of proteins extracted from leukocytes was also performed.

RESULTS

Five mutations were identified in these five families, each with one distinct mutation: three frameshift, one nonsense, and one splicing. Two of these were novel mutations: c.627dupA in exon 5 and c.703-1G>C in intron 5. The truncating nature of the mutations was experimentally proved by PTT for four families with second samples collected. In particular, c.703-1G>C spliced exon 5 directly to exon 7 and deleted the entire exon 6 from the transcript. Direct immunoblot analysis failed to detect REP-1 in males affected by CHM, but demonstrated its presence in female carriers and homozygous normal females.

CONCLUSIONS

This is the first study reporting mutations in the CHM gene in Chinese families. Mutational analysis was performed at the DNA, mRNA and protein levels. Five truncating mutations were found, and two of these were novel.

摘要

目的

脉络膜视网膜病变(CHM)是一种由CHM基因突变引起的X连锁视网膜退行性疾病。这些突变导致Rab护送蛋白1(REP-1)功能异常。在本研究中,对5个临床诊断为CHM的中国家系进行了CHM基因突变分析。

方法

采用变性高效液相色谱法对CHM基因的所有15个外显子和侧翼内含子区域进行突变筛查。通过DNA测序确认并鉴定突变。随后采集第二份样本用于从白细胞中提取mRNA和蛋白质。开发并使用非放射性蛋白截短试验(PTT)来鉴定突变的截短性质。还对从白细胞中提取的蛋白质进行了免疫印迹分析。

结果

在这5个家系中鉴定出5个突变,每个家系有一个独特的突变:3个移码突变、1个无义突变和1个剪接突变。其中2个是新突变:外显子5中的c.627dupA和内含子5中的c.703-1G>C。对于采集了第二份样本的4个家系,通过PTT实验证明了突变的截短性质。特别是,c.703-1G>C将外显子5直接剪接到外显子7,并从转录本中删除了整个外显子6。直接免疫印迹分析未能在受CHM影响的男性中检测到REP-1,但在女性携带者和纯合正常女性中证明了其存在。

结论

这是第一项报道中国家系中CHM基因突变的研究。在DNA、mRNA和蛋白质水平上进行了突变分析。发现了5个截短突变,其中2个是新突变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验